Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant

References

ref title DOI material type comment
3626 438 Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant https://doi.org/10.1002/advs.202000771 Metal oxide chitosan (CS) functionalized iron oxide nanozymes (CS-IONzymes)

Materials

ref material size size err size unit size type size comment BET b nanozyme b 10n b unit specific act sa 10n sa unit comment
7669 438 CS-IONzyme 250 nm TEM Three kinds of chitosan (low (50–190 KDa), medium (190–310 KDa), and high (310–375 KDa) molecular weight) functionalized IONzyme (named CS-IONzyme) were spheres of ≈250 nm in diameter, which were a bit bigger than IONzyme

Kinetics

ref material enzyme type substrate pH T km km err km 10n km unit vmax vmax err vmax 10n vmax unit kcat kcat err kcat 10n kcat unit kcat/km kcat/km 10n kcat/km unit comment

Applications

ref material application target method linear range linear ran unit LOD lod unit recovery comment
5350 438 CS-IONzymes provides an antiviral alternative for designing nasal vaccines based on IONzyme to combat influenza infection This work provides an antiviral alternative for designing nasal vaccines based on IONzyme to combat influenza infection.
5349 438 CS-IONzymes provides an antiviral alternative for designing nasal vaccines based on IONzyme to combat influenza infection